Whitehawk Therapeutics, Inc.
WHWK
$1.65
$0.000.00%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -1.30% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -1.30% | |||
| Cost of Revenue | 411.20% | -36.92% | |||
| Gross Profit | -1,931.17% | 69.57% | |||
| SG&A Expenses | -53.65% | 15.96% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 144.82% | -14.61% | |||
| Operating Income | -259.76% | 19.69% | |||
| Income Before Tax | -172.06% | 499.58% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -172.06% | 499.58% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -172.06% | 499.58% | |||
| EBIT | -259.76% | 19.69% | |||
| EBITDA | -261.01% | 19.79% | |||
| EPS Basic | -141.35% | 373.04% | |||
| Normalized Basic EPS | -109.23% | 46.04% | |||
| EPS Diluted | -141.62% | 371.27% | |||
| Normalized Diluted EPS | -110.81% | 46.44% | |||
| Average Basic Shares Outstanding | 74.27% | 46.35% | |||
| Average Diluted Shares Outstanding | 73.00% | 47.42% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||